TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).

Brigette B Y Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.